Poor Prognosis of HIV-Associated Tuberculous Meningitis Regardless of the Timing of Antiretroviral Therapy
Authors:
Open Access
- 1 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (11) , 1384-1387
Abstract
(See the article by Török et al, on pages 1374–1383 .)Keywords
This publication has 26 references indexed in Scilit:
- Optimum time to start antiretroviral therapy during HIV-associated opportunistic infectionsCurrent Opinion in Infectious Diseases, 2011
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort studyBMJ, 2010
- Early versus Delayed Initiation of Antiretroviral Therapy for Concurrent HIV Infection and Cryptococcal Meningitis in Sub‐Saharan AfricaClinical Infectious Diseases, 2010
- The HIV-associated tuberculosis epidemic—when will we act?The Lancet, 2010
- Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settingsCurrent Opinion in HIV and AIDS, 2010
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy TrialPLOS ONE, 2009
- Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.2009
- Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal studyThe Lancet, 2006
- Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and AdultsNew England Journal of Medicine, 2004